Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/EUCTR2005-003662-41-PT
EUCTR2005-003662-41-PTActive, not recruitingNot Applicable

Enzymatic Debridement in Burns Patients (Children & Adults): A Comparison to Standard of Care (Protocol MW 2004-11-02)

MediWound Ltd0 sites172 target enrollmentStarted: January 3, 2006Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
172
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • •1. Males and females between 4 years to 55 years of age,
  • •2. Thermal burns caused by fire/flame, scalds or contact,
  • •3. Deep partial thickness (mixed deep dermal) and/or full thickness (3°) burn wounds = 5% and = 30% Total Body Surface Area (TBSA); all these wounds must receive study treatment,
  • •4. At least one wound of = 2% TBSA deep partial thickness and/or full thickness burn,
  • •5. At least 50% of the deep partial thickness and/or full thickness burn wounds or burn wound area of the patient is intended for tangential excision as judged at hospital admission,
  • •6. Total burn wounds = 30% TBSA,
  • •7. Hospital admission within 24 hours of the burn injury. Patients transferred from another hospital/clinic may be enrolled if the primary admission was within 24 hours of the burn injury and admission to the burn unit participating in the study was within 48 hours of the burn injury,
  • •8. Signed written informed consent.
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range:
  • •F.1.2 Adults (18-64 years) yes
  • •F.1.2.1 Number of subjects for this age range
  • •F.1.3 Elderly (>=65 years) no
  • •F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • •1. Other severe cutaneous trauma at the same sites as the burns (i.e. blunt, avulsion or deep abrasion) or previous burn(s) at the same treatment site(s) or one or more burn wounds that do not meet study criteria,
  • •2. Deep partial thickness and/or full thickness facial burn wounds, > 0.5% TBSA; study treatment of facial burns is not allowed,
  • •3. Study treatment of perineal and/or genital burns,
  • •4. Circumferential anterior/posterior trunk full thickness fire/flame burns, > 15% TBSA, (Circumferential is defined as encircling = 80% of the trunk circumference.)
  • •5. Pre-enrollment dressings other than: none, dry clean, moist clean, saline, Silver Sulphadiazine (SSD), or 3%-5% Sulfamylon,
  • •6. Pre-enrollment escharotomy,
  • •7. Heavily contaminated burns or pre-existing infections (Adults: WBC = 20.0 cells/µL; Children aged 4-16: WBC = 25.0 cells/µL),
  • •8. Signs that may indicate smoke inhalation,
  • •9. General condition of patient would contraindicate surgery,
  • •10. Prisoners,
  • •11. Pregnant women (positive pregnancy test) or nursing mothers,
  • •12. Poorly controlled diabetes mellitus (HbA1c>9%),
  • •13. Cardio-pulmonary disease (MI within 4 weeks prior to injury, pulmonary hypertension, COPD or pre-existing oxygen-dependent pulmonary diseases),
  • •14. Pre-existing diseases which interfere with circulation (PVD, edema, lymphedema, surgery to the regional lymph nodes, obesity, varicose veins),
  • •15. Immediate life threatening conditions (such as immuno-compromising diseases, life threatening trauma, severe pre-existing coagulation disorder, cardiovascular, liver or neoplastic disease),
  • •16. Chronic systemic steroid intake,
  • •17. History of allergy, atopic disease or known sensitivity to pineapples or papain,
  • •18. Suicide attempts,
  • •19. Participation in another investigational drug trial,
  • •20. Current alcohol or drug abuse.

Investigators

Similar Trials

Completed
Phase 3
Enzymatic Debridement in Burns Patients (Children and Adults): A Comparision to Standard of Care (Protocol MW2004-11-02)
CTRI/2009/091/000413MediWound Ltd.270
Active, not recruiting
Not Applicable
Enzymatic Debridement in Burns Patients (Children & Adults): A Comparison to Standard of Care (Protocol MW 2004-11-02)Burn wounds defined as deep partial thickness or full thickness thermal burns.
EUCTR2005-003662-41-DEMediWound Ltd270
Active, not recruiting
Not Applicable
Enzymatic Debridement in Burns Patients (Children & Adults): A Comparison to Standard of CareAdult and children patients with burn wounds defined as deep partial thickness or full thickness thermal burns requiring hospitalization.MedDRA version: 14.1Level: SOCClassification code 10022117Term: Injury, poisoning and procedural complicationsSystem Organ Class: 10022117 - Injury, poisoning and procedural complications
EUCTR2005-003662-41-ITMEDIWOUND270
Active, not recruiting
Phase 1
Enzymatic Debridement in Burns Patients (Children & Adults): A Comparison to Standard of Care (Protocol MW 2004-11-02)
EUCTR2005-003662-41-SKMediWound Ltd172
Active, not recruiting
Phase 1
Enzymatic Debridement in Burns Patients (Children & Adults): A Comparison to Standard of Care (Protocol MW 2004-11-02)Burn wounds defined as deep partial thickness or full thickness thermal burns.
EUCTR2005-003662-41-CZMediWound Ltd172